12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's pre-market session, health care stocks saw significant movements. vTv Therapeutics led the gainers with a 104.2% increase, while Oragenics experienced the largest drop, falling 45.3%. Other notable movers include Vivani Medical and Genetic Technologies with substantial gains, and Vicarious Surgical and ProKidney among the losers. Ventyx Biosciences and Inogen reported Q4 earnings, impacting their stock prices.
February 28, 2024 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
vTv Therapeutics shares surged 104.2% in pre-market trading, with a market value of $35.3 million.
The substantial increase in vTv Therapeutics' stock price indicates strong investor interest, likely due to positive developments or expectations, leading to a bullish short-term outlook.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Ventyx Biosciences shares increased by 12.89% to $6.83, with a market cap of $403.2 million, following their Q4 earnings report.
The positive movement in Ventyx Biosciences' stock price post-Q4 earnings suggests the market reacted favorably to the earnings report, indicating a bullish short-term outlook.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Inogen shares fell 14.46% to $7.99, with a market value of $186.2 million, after releasing their Q4 earnings.
The decline in Inogen's stock price following their Q4 earnings release suggests the market may have reacted negatively to the earnings report, indicating a bearish short-term outlook.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Oragenics stock fell sharply by 45.3% in pre-market trading, with a market value of $4.1 million.
The significant drop in Oragenics' stock price suggests negative sentiment or disappointing news, leading to a bearish short-term outlook for the stock.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100